Trials / Unknown
UnknownNCT01587326
The Effects of Escitalopram on Cytokines
The Effects of Escitalopram on Cytokines in Depressive Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Beitou Armed Forces Hospital, Taipei, Taiwan · Other Government
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The association of cytokines with escitalopram has not been investigated in patients with major depressive disorder (MDD). Hence, the investigators will examine this association.
Detailed description
In addition to serotonin, inflammatory process has been suggested in the development of major depressive disorder (MDD) and in its associated treatment. Escitalopram is an antidepressant that has been widely used in patients with MDD because of the promising results. The association of cytokines with escitalopram has not been investigated in patients with MDD. Hence, the investigators will examine this association.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram | escitalopram 10 mg/d to 20 mg/d |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2012-04-30
- Last updated
- 2012-05-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT01587326. Inclusion in this directory is not an endorsement.